“The first 100 beneficiaries of such foreign vaccines shall be assessed for seven days for safety outcomes before it is rolled out for further immunisation programme within the country,” the health ministry said in a statement.
* India’s health ministry said on Tuesday its drug regulator had found that safety and immunogenicity data from a local trial of Russia’s Sputnik V coronavirus vaccine was comparable to that of a late-stage trial done in Russia.
The vaccine has now been “recommended for grant of permission for restricted use in emergency situations subject to various regulatory provisions”, the ministry said, commenting on the approval earlier confirmed by the drug’s marketing agencies.
The vaccine can now be imported, it said.
* India reported 161,736 new coronavirus infections on Tuesday, hitting the world’s highest daily tally once again, for a total of 13.69 million cases, health ministry data showed.
Deaths rose by 879 to 171,058. Numbers typically fall on Tuesdays because of delayed results from tests done on weekends.